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bating cytosol of bovine liver with radioactively labeled
-tocopherol [10]. Besides the well-known -tocopherol
transfer protein (-TTP), another protein was labeled by
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Clemens Schulze-Briese,2 and Ulrich Baumann1
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University of Berne this procedure and characterized by N-terminal se-
quencing. The human homolog of this protein wasFreiestrasse 3, 3012 Bern
Switzerland cloned and termed tocopherol associated protein (TAP)
due to its ability to bind -tocopherol [11]. However,2 Paul-Scherrer-Institut
CH-5232 Villigen PSI attempts to isolate a 1:1 TAP-tocopherol complex failed.
Later, TAP was found by Arai and coworkers to beSwitzerland
identical to SPF [12] and termed “squalene transfer pro-
tein” due to enhanced sterol production in SPF-trans-
fected cells as well as squalene transfer activity in vitroSummary
[12]. Again, no evidence for a direct interaction of squa-
lene with TAP/SPF was found by this group, hence theSupernatant protein factor (SPF) promotes the epoxi-
in vivo ligand specificity of SPF and its physiologicaldation of squalene catalyzed by microsomes. Several
role still remain unclear.studies suggest its in vivo role in the cholesterol bio-
Sequence analysis indicated that TAP/SPF is a membersynthetic pathway by a yet unknown mechanism. SPF
of the widespread Sec14-like protein family having a char-belongs to a family of lipid binding proteins called
acteristic lipid binding domain called CRAL_TRIO [13].CRAL_TRIO, which include yeast phosphatidylinositol
Prominent members of the CRAL_TRIO family are Sec14transfer protein Sec14 and tocopherol transfer protein
from Saccharomyces cerevisiae, human -tocopherolTTP. The crystal structure of human SPF at a resolution
transfer protein and cis-retinal binding protein. In the hu-of 1.9 A˚ reveals a two domain topology. The N-terminal
man genome, there are three highly conserved homologs275 residues form a Sec14-like domain, while the C-ter-
of TAP/SPF (GenBank entries AAF19258.1, AAF19259.1,minal 115 residues consist of an eight-stranded jelly-
and XP_092896.1). The physiological function of noneroll barrel similar to that found in many viral protein
of these genes has been characterized yet.structures. The ligand binding cavity has a peculiar
The crystal structure of Sec14, a phosphatidylinositol-horseshoe-like shape. Contrary to the Sec14 crystal
transfer protein from yeast and prominent member ofstructure, the lipid-exchange loop is in a closed con-
the CRAL_TRIO family, has been determined some yearsformation, suggesting a mechanism for lipid exchange.
ago [14] in complex with -octyl-glucoside as a lipid
mimic. The Sec14 gene product plays an essential role
Introduction in yeast Golgi secretory function by maintaining a Golgi
phosphatidylcholine composition that permits efficient
Cholesterol is not uniformly distributed in eukaryotic transport of proteins from this organelle [15]. The pres-
cells [1]. The plasma membrane accommodates the ma- ence of a Sec14-like lipid binding domain in TAP/SPF
jor part of the intracellular cholesterol content in cells provides an identification of a putative ligand binding
whereas major parts of sterol biosynthetic activity are site in this molecule.
concentrated in the relatively cholesterol poor endo- The object of this study was to assess the three-
plasmic reticulum [2]. The conversion of squalene to dimensional structure of human TAP/SPF in order to
squalene-(2,3)-oxide by microsomal squalene monoox- gain a deeper understanding of its hypothetical ligand-
ygenase represents a key reaction of the cholesterol transfer function.
biosynthesis and is therefore tightly controlled [3, 4]. Here we report the X-ray crystallographic structure of
The reaction requires both the microsomal and cytosolic human supernatant protein factor (TAP/SPF) deter-
fraction of liver, along with O2 and NADPH [5]. In 1957 mined at 1.90 A˚ resolution, showing that the three-
Bloch and colleagues identified a 47 kDa protein in rat dimensional structure consists of an N-terminal SEC14-
liver cytosol that they later termed “supernatant protein like domain with a horse shoe-shaped ligand binding
factor” (SPF) due to its ability to stimulate microsomal cavity and a C-terminal jelly-roll.
squalene epoxidation [6].
In a first hypothesis, it was proposed that SPF facili- Results
tates the access of substrate to specific enzyme sites
by interacting with the microsomal membrane [7]. Later TAP/SPF was crystallized in spacegroup P1 with three
findings by the same group excluded a conventional molecules per asymmetric unit and was refined to an
squalene carrier function for SPF, suggesting an involve- Rfree of 0.228 at 1.90 A˚ resolution. Our current TAP/SPFment of the unsaturated fatty acid moiety of anionic model (Figure 1) comprises residues 1–397. The N-ter-
phospholipids in the promotion of SPF-mediated squa- minal three-linker amino acids from the cloning con-
lene uptake by microsomes [8, 9]. struct and the seven C-terminal amino acids are not
In 1999 our group identified a 46 kDa protein by incu-
Key words: crystal structure, squalene, tocopherol, phosphatidyl-
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Figure 1. Crystal Structure of TAP/SPF
(A) Ribbon cartoon of TAP/SPF. The color gradient goes from blue (N terminus) to red (C terminus) with exception of the lipid-exchange loop
(H9-H10) colored in yellow and the C-terminal helix shown in magenta. The Sec14 domain is in the lower part of the molecule with the lipid-
exchange loop (residues 195:215) highlighted in yellow. The jelly-roll domain is on the top of the molecule. Only helices with more than three
residues were included in the secondary structure. The cavity surface is shown in gray. All figures were prepared using PYMOL (Warren
Delano, http://www.pymol.org).
(B) Labeled C trace of TAP/SPF. The SEC14 domain is shown in blue and the jelly-roll in red. The lipid exchange loop is colored yellow and
the C-terminal helix magenta. The figure is rotated by 40 around the vertical compared to Figure 1A.
visible. In two of the three crystallographically indepen- 275–300) connecting the Sec14 and jelly-roll domain. An
overlay (program LSQMAN [20]) of the Sec14 structuredent molecules, the residues 226–232 that form a pro-
truding loop connecting two  strands in the jelly-roll (PDB code 1AUA) with SPF yielded a RMS deviation of
1.6 A˚ for 210 C atoms in this domain.domain are disordered. The three molecules show quite
substantial deviations from each other, e.g., a deviation The central  sheet on the one side and helices 6–10
on the other side enclose a rather large (1318 A˚3 ) hy-of 0.45 A˚ is observed between the C atoms of the N-ter-
minal domains of molecule 1 and molecule 3, and a RMS drophobic ligand binding pocket. Contrary to Sec14,
however, the entrance to this cavity is blocked by helicesdifference of 1.6 A˚ for the jelly-roll domains of molecules
1 and 2. Molecules 2 and 3 show RMS deviations of 9 and 10 and the connecting loop. The conformation of
this segment, termed hereafter lipid-exchange loop, is0.45 and 1.7 A˚ for the N- and C-terminal domains, re-
spectively. These deviations arise from rigid body move- very different in Sec14, where the helices are rotated
away from the sheet, opening the mouth of the pocketments and local distortions due to different crystal pack-
ing environments. In particular, the jelly-roll domain and thereby exposing an extended hydrophobic patch
comprising Leu227, Phe228, and Phe231 (correspond-shows a high plasticity.
The overall structure of SPF is depicted in Figure 1 ing to Leu204, Ile205, and Phe208 in SPF) to the solvent
side. This exposed hydrophobic segment is stabilizedand consists of 13  strands, 11  helices, and 8 310
helices as identified by the program STRIDE [16]. Six of by interactions with the same residues from a symmetry-
related molecule; in other words, a hydrophobic wedgethose 310 helices are only three residues in length and
not shown in Figure 1. SPF folds into two domains: the consisting of the residues mentioned above is inserted
into the mouth of the ligand binding pocket, hence forc-N-terminal 275 residues form a Sec14-like domain while
the C-terminal 115 residues consist of an eight-stranded ing the pocket open in this crystallographic dimer of
Sec14 (Figure 2).jelly-roll “barrel” similar to that found in many viral pro-
tein structures [17, 18]. In our TAP/SPF structure, where no such crystal con-
tacts are observed, helix 9 is rotated by about 80 com-
pared to Sec14, which results in a shift of about 14 A˚.The Sec14-like Domain
The hydrophobic side of helix 10 now sits on the mouthThe N-terminal domain consists of a central five-
of the pocket while the more polar site faces the solvent.stranded mixed  sheet with a topology (1, 1x, 1x, 1x)
This conformation of segment 198–215 is further stabi-where the parallel strands are connected by right-
lized by interactions with the very C-terminal helix 13,handed -- motifs [19]. In this way the helices 6, 7,
which packs against helix 9.and 8 pack against one face of the sheet. The other side
of the  sheet is mainly covered by a long loop (residues The cavity itself has a peculiar horseshoe shape, dif-
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Figure 2. Overlay Sec14 (blue) and TAP/SPF
(red)
The lipid-exchange loops from Sec14 (high-
lighted in cyan) and TAP/SPF (yellow) are in
very different conformations. In TAP/SPF the
loop closes the ligand binding site and is
locked in this conformation by the C-terminal
helix shown in magenta. The conformation
observed in Sec14 in the presence of -octyl-
glucoside belongs probably to the mem-
brane-associated form.
ferent from the one in Sec14. The center of the ring is sity. The occupancy is rather low, as can be concluded
from the rather high B-factors (Table 1).occupied by two tyrosine side chains (residues 153 and
171) hydrogen bonded to each other (Figure 3), dividing
in this way the pocket into two branches. The pocket The Jelly-Roll Domain
The C-terminal residues 290–395 fold into an eight-is mostly lined by hydrophobic amino acid side chains.
An exception is the presence of aspartic acid 101, which stranded antiparallel  sandwich consisting of two four-
stranded antiparallel  sheets, each with topologyreplaces the equivalent Glu124 in Sec14. Glu127, corre-
sponding to Glu150 in Sec14, points now to the inside (–2x, 1, 2x), similar to the jelly-roll domains of many
viral proteins. Performing a database search using DALI,of the pocket, forming a salt bridge with Lys124, which
replaces Leu147 in Sec14. the top hit was satellite tobacco necrosis virus (PDB
code 2STV) with a Z score of 7.4 [21] and an RMS devia-The other branch of the pocket corresponds roughly
to the location where the “inner” -octylglucoside mole- tion of 2.7 A˚ for 101 C atoms. Frequently, these domains
bind to specific ligands, such as cell surface-attachedcule is found in the Sec14 structure. Already during the
early stages of protein purification, mass spectrometry carbohydrate substrates for galactose oxidase and siali-
dase, or phospholipids on the outer side of the cellhad revealed the presence of an unidentified ligand,
probably originating from E. coli, with a mass of 349  membrane for coagulation factor Va [22].
4 Da. Residual weak electron density in this part of the
pocket clearly indicates the presence of an alkyl chain The Ligand
Electrospray mass spectrometry was employed to ex-with length 16 carbon atoms (Figure 4), but attempts
for a closer characterization of this ligand proved to be amine ligand binding. The putative E. coli ligand of TAP/
SPF was exchanged by incubating the protein in theunsuccessful. For the sake of crystallographic refine-
ment, the ligand was tentatively modeled as palmitate presence of an excess of -octylglucoside. Accordingly,
a complex of phosphatidylinositol and TAP/SPF was(mass 255.4) to fill the more continuous part of the den-
Figure 3. The Ligand Binding Cavity
The cavity surface was calculated with VOI-
DOO [48]. The lining is generally hydrophobic;
however, some polar amino acids are present
as well, e.g., Lys124, Glu127, and Asp101.
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Figure 4. Stereo Figure of the Residual Elec-
tron Density of the Unknown E. coli Ligand
Shown is the 2Fo  Fc density map (cyan
mesh) contoured at 1.0 sigma above the
mean. The map was computed before any
ligand atoms were put into the model. The
ligand modeled as palmitate is shown in ma-
genta, internal water molecules as red balls.
prepared using phospholipid liposomes. In both cases, Our data indicate that the putative E. coli ligand was
exchanged completely by-octylglucoside as well as byconcentrations well above the respective CMC of the
compound were crucial for complex formation. At- phosphatidylinositol, indicating that both compounds
bind to the same site of the cavity of TAP/SPF. Neverthe-tempts to prepare ligand complexes of TAP/SPF with
-tocopherol or squalene under similar conditions less, it should be noted that this method does not allow
a quantitative analysis of ligand complex formation. Theproved to be unsuccessful (data not shown). The observed
mass peak ratios of apo-TAP/SPF (46437  4 Da) versus peaks corresponding to the apo-protein are invariably
the highest in the mass spectra, which can be interpre-ligand complexes were 4:1, 4:1, and 2:1 for the E. coli
ligand (46789 4 Da), -octylglucoside (46724.4 6 Da), ted either as incomplete occupancy or as dissociation
of the complex due to the rather harsh conditions in theand phosphatidylinositol (47339.6 7 Da), respectively.
ESI-MS or during sample preparation.
Table 1. Crystallographic Statistics Discussion
Source SLSd ID14-4e
Sec14-like proteins are crucial lipid carriers involved inData collection
the control of the lipid composition of biological mem-
Peak wave length (A˚) 0.97884 0.97950 branes. These proteins regulate major steps of biosyn-
No. of crystals 2 1 thetic pathways of lipids by regulating the local abun-
Resolution range (A˚) 20.–2.05 40.–1.90
dance of their precursors. A subset of Sec14-like(Outer shell) (2.05–2.00) (1.95–190.)
proteins are reported in Pfam (CRAL_TRIO, PF00650)No. observations 715,326 660,950
No. unique reflections 184,572 215,407 and Prosite (profile, PS50191) entries. Among these pro-
Completeness (%) 97.1 (97.1) 96.2 (95.2) teins, the archetypical member is Sec14 from Saccharo-
Rsyma 0.093 (0.251) 0.084 (0.257) myces cerevisiae. The biological function of Sec14 has
I/ 15.7 (3.9) 10.9 (4.4) been studied in detail by several groups showing that
Phasing this protein maintains a reduced Golgi membrane phos-
phatidylcholine (PC) content, which is essential for GolgiFOMc 0.34 0.31
secretory function and cell viability [15, 23, 24]. TheFOM after solvent modification 0.58 0.57
collective data suggest that the phosphatidylcholine-
Refinement
bound form of Sec14 effects an essential repression
Resolution range 20.–2.05 40.–1.90 of CDP-choline pathway activity in yeast Golgi mem-
No. reflections working setb 177,988 209,964 branes by inhibiting choline-phosphate cytidyltransfer-
No. reflections test set 2,836 4,126
ase (CCTase; EC 2.7.7.15).No. atoms total 10,206 10,206
A segment apparently crucial for lipid transfer is theProtein 9,504 9,504
lipid-exchange loop mentioned above, which consistsLipid 52 52
Waters 648 648 of residues 191–215 in TAP/SPF. In Sec14, which was
B-factor overall (A˚2) 26.5 28.7 crystallized in the presence of -octylglucoside, this
Protein 25.8 28.1 loop adopts an open conformation exposing a hy-
Lipid 50.0 52.2
drophobic patch to the exterior side of the molecule.Waters 34.1 36.3
This conformation in Sec14 is stabilized by dimerizationR (%) 20.5 21.4
of the molecules in the crystal lattice. A similar openRfree (%) 22.7 23.2
RMS bonds (A˚) 0.005 0.005 conformation in a dimer has been observed recently in
RMS angles (degrees) 1.2 1.2 the structure of the nonhomologous apo-phosphatidyl-
inositol transfer protein  (PITP-) [25], where this con-a Rsym	 hkl  j|I(hkl;j)  I(hkl)|/( hkl  j I(hkl)).
b Friedel pairs were treated as different reflections. formation has been assigned to the membrane-bound
c Figure-of-merit as computed by SOLVE and RESOLVE. form with the exposed hydrophobic residues anchoring
d Swiss Light Source beam line X06SA, Villigen, Switzerland. the lipid-charged molecule to the membrane. Here, as
e ESRF Grenoble, beam line ID14-4.
well as described for Sec14 above, the open conforma-
Human Supernatant Protein Factor
1537
tion is stabilized or possibly even induced by dimeriza- with the Golgi membrane by interaction of its C-terminal
domain with the Golgi membrane protein giantin [29].tion, where the hydrophobic lipid-exchange loop from
a crystal symmetry-related molecule inserts partially The latter could suggest that the jelly-roll domain may
be involved in binding to other Golgi proteins.into the binding pocket. On the contrary, in the crystal
structure of the complex of PITP- with phosphatidyl- TAP/SPF has been described by several groups to
enhance microsomal squalene epoxidation and in con-choline [26] ,where no such crystal interactions are ob-
served, the lipid-exchange loop adopts a closed confor- sequence has led to the hypothesis that the observed
stimulation includes a TAP/SPF-mediated transfer ofmation.
The conformation of the lipid-exchange loop in our squalene between separate membranes. The original
squalene transfer hypothesis was coupled to the ideaTAP/SPF structure is very different from that observed in
Sec14, with the previously exposed hydrophobic patch that this activity has an in vivo role in cholesterol biosyn-
thesis. Due to the fact that no conventional protein car-facing the inside of the ligand binding cavity. Conse-
quently, our TAP/SPF structure represents the “carrier”- rier function or squalene binding could be detected, the
same authors modified their hypothesis in such a waystate of the molecule, where the resident lipid molecule
is enclosed in the hydrophobic pocket and the protein is that TAP/SPF stimulates the cholesterol biosynthesis
in a more indirect way by controlling the microsomalnot in contact with the membrane bilayer. This notion
is supported by fact that TAP/SPF was isolated as a squalene uptake. It was then reported that enhanced
microsomal squalene uptake mediated by TAP/SPF re-soluble monomeric molecule in the absence of deter-
gents. quires the presence of anionic phospholipids such as
phosphatidylinositol, which forms a stable complex withAn interesting question concerns the details of the
lipid exchange mechanism. A reasonable model describes TAP/SPF, and that the capacity of the anionic phospho-
lipids to bind to TAP/SPF parallels their ability to en-the advent of the lipid-bound TAP/SPF protein at the
membrane surface with the lipid-exchange loop closed. hance the stimulatory activity of TAP/SPF [30]. In agree-
ment with these later reports, we did not find any signThe surrounding of the lipid-exchange loop is still quite
hydrophobic (solvent-exposed residues Ile296, Leu297, of a physical interaction between TAP/SPF and squa-
lene, but instead we could show physical binding toPhe298, and Pro299) facilitating docking to the mem-
brane. The question arising now is whether interaction phosphatidylinositol. Altogether this leads us to specu-
late that the abundance of the cholesterol precursorwith the membrane lipids is sufficient for the opening
of the lipid-exchange loop or whether dimerization is squalene in the microsomal membrane seems to de-
pend on the presence of TAP/SPF and phosphatidylino-required as well. In the case of TAP/SPF, it is first neces-
sary to push the C-terminal helix away from the lipid- sitol, which in turn may show up as key elements in the
regulation of the de novo synthesis of cholesterol inexchange loop in order to open the pocket and to release
the bound ligand into the membrane. In case of a lipid eukaryotes.
It will be important to determine whether interactionsexchange, another lipid molecule has to get pulled out
of the membrane followed by loop closure and concomi- involving the jelly-roll domain have a role in targeting
TAP/SPF to specific cellular sites. The nature of thetant dissociation of the complex from the membrane.
It has been reported that Sec14 localizes as a periph- supposed physical partners of TAP/SPF as well as the
mechanism of lipid bilayer modifications is yet to beeral membrane protein that can be recovered in stable
association with highly enriched yeast Golgi membranes elucidated. It should now be possible to design struc-
ture-based mutations that alter protein-ligand interac-[27]. In later experiments, it was shown that the N-ter-
minal 129 residues are sufficient for Golgi targeting and tions as well as subcellular targeting in order to allow
studies on the physiological significance of this protein.colocalize with the Golgi marker KEX2p in vivo [28].
Analysis of several N-terminal Sec14-like sequences
from different species revealed the presence of a seg-
Biological Implicationsment of especially high conservation (60%), which rep-
resents helix two of the coiled-coil motif in Sec14 (resi-
Sec14-like proteins are lipid carriers of vital importancedues 56–72) as well as in TAP/SPF (residues 34–50) and
that are involved in phospholipid metabolism, signal-TTP (residues 48–64). Our findings indicate that the
transduction, and vesicular trafficking [31]. They form asurface segment of Sec14 that interacts with the Golgi
rather large protein family called CRAL_TRIO [13], in-apparatus has a common coiled-coil topology shared
cluding, for example, Sec14 from yeast and humanwith TAP/SPF and several other Sec14-like proteins.
-tocopherol transfer protein [32]. So far, from this familyA database search showed 55% sequence similarity
only the three-dimensional structure of Sec14 has beenwithin 160 amino acids of the jelly-roll domain of TAP/
determined [14]. Here we report the crystal structure ofSPF to the C-terminal extensions of squid retinal binding
human tocopherol-associated protein/supernatant pro-protein RALBP (amino acids 184–334; Swiss-Prot ac-
tein factor (TAP/SPF), a protein that enhances choles-cession P49139), 47% similarity within 84 amino acids
terol biosynthesis by stimulation of the squalene epoxi-with the human FYVE and coiled-coil domain-containing
dase activity and that binds to phospholipids.protein (amino acids 1388–1469; GenBank AJ292348),
TAP/SPF consists of two domains: the N-terminal li-and 39% within 141 amino acids to the human Golgi
gand binding domain shows the typical Sec14 foldphosphoprotein GCP60 (amino acids 384–524; GenBank
where the ligand binding site resides in a cavity betweenAB043587) and its mouse ortholog peripheral benzodi-
the central  sheet and the surrounding helices. Twoazepine receptor-associated protein (GenBank AF022770).
GCP60 has previously been shown to be associated important differences to Sec14 are notable: (i) the cavity
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SPF and 33 
mol octyl -D-glucopyranoside or 11 
mol phosphati-has a peculiar horseshoe-like shape with two tyrosine
dylinositol, respectively. Prior to electrospray mass spectrometryside chains in the center, and (ii) the entrance to the
(ESI-MS), samples were dialyzed overnight against water at 4C andbinding site is closed. While in Sec14 dimerization via
then diluted in solvent containing CH3CN/H2O (1:1 v/v) and 0.5%crystal symmetry stabilizes an open conformation, we HCOOH.
find in our structure that the segment 196–215 (called
lipid-exchange loop) adopts a different conformation in Crystallization
Purified TAP/SPF was equilibrated in a buffer containing 2 mMsuch a way that the hydrophobic patch, which is ex-
EDTA, 2 mM DTT, 40 mM NaCl, 20 mM Tris-HCl (pH 7.4) and concen-posed in the open form, now faces the ligand binding
trated to 20 mg/ml by Centriprep-10 (Millipore AG, Volketswil, Swit-cavity. This conformation is stabilized further by the
zerland). The protein was checked for completeness of thrombin
C-terminal helix of the C-terminal jelly-roll domain. The digestion and degradation by gelfiltration and ESI-MS. The seleno-
N terminus of TAP/SPF is similar to Sec14 consisting of methionine (SeMet)-labeled TAP/SPF was prepared by the method
a conserved three-helix coil, which is responsible for of methionine biosynthesis inhibition [34] and purified as the wild-
type. A substitution ratio of 100% was determined by ESI-MSthe localization at the Golgi apparatus. The C-terminal
(data not shown). Native crystals of TAP/SPF were obtained at 18C120 amino acids fold into an eight-stranded jelly-roll 
by sitting-drop vapor diffusion. Drops were set up by mixing of 1sandwich similar to the folding motif frequently found

l of TAP/SPF solution with 4 
l of reservoir solution (containing
in viral proteins or receptor binding domains. The func- 20% [w/v] polyethylene glycol 3350, 5% [w/v] glycerol, 200 mM
tion of this domain is not clear now, but it is tempting NaCitrate [pH 8.3]) and equilibrated against 100 
l reservoir solution
to speculate that it mediates binding to a further Golgi at 18C. Crystals were observed after 7–14 days and grew to an
average size of 0.05  0.10  0.20 mm3 . Crystals of the SeMet-protein. This notion is supported by the sequence ho-
labeled TAP/SPF were obtained under identical conditions. Themology to the human Golgi phosphoprotein GCP60 [29].
crystals belong to the space group P1 with a	 60.34 A˚, b	 84.33 A˚,
c	 87.06 A˚, 	 116.20, 	 102.52, 	 100.07 degrees and containExperimental Procedures
three molecules per asymmetric unit. Before data collection the
crystals were flash-cooled in a nitrogen stream at 110 K after raisingProtein Expression and Purification
the glycerol concentration of the crystallization solution in steps ofThe N-terminal (His)6-tagged TAP/SPF overexpression vector was
5% to 20% (w/v) glycerol. Data were collected at the synchrotronconstructed by cloning a PCR product derived from a human cDNA
beam lines ID14-4 in Grenoble and SLS (PSI Villigen) at 100 K,library into the NdeI-EcoRI sites of the pET-28b vector. The oligonu-
employing a QUANTUM-4 (ADSC, San Diego) and MAR-165 CCDcleotide primers used for PCR were 5-CGCGGCAGCCATATGAGC
(MAR Xray-research, Hamburg, Germany) detector, respectively.GGCAGAGTCGGCGA and 5-CCGGAATTCTCATTTCGGGGTGCCT
Oscillation ranges for each image ranged between 0.5 and 1.0 de-GCCCCCA with the NdeI and EcoRI sites underlined. The N-terminal
grees with typical exposure times of 1 s per image. Crystal-to-(His)6-tagged TAP/SPF construct was transformed into E. coli BL21-
detector distances varied from 130 mm to 250 mm.Star (DE3) (Invitrogen, Carlsbad, CA). Cells were cultured overnight
with agitation at 37C in 120 ml Luria-Bertani (LB) medium containing
Structure Solution and Refinement30 
g/ml kanamycin. The overnight culture was used to inoculate
Since initial attempts to solve the structure by molecular replace-8 liters of LB medium (30 
g/ml kanamycin). The culture was grown
ment using the Sec14 model (PDB code 1AUA) were unsuccessful,at 25C to an OD600 of 0.5 and then induced with 1 mM isopropyl-
the structure was solved by means of the SAD method using SeMetthiogalactopyranoside (IPTG) for 12 hr. Cells were harvested by
labeled protein [35, 36].centrifugation at 5000  g for 5 min and resuspended in 250 ml of
A SAD dataset was collected at the beam line X06SA at the Swissice-cold binding buffer (20 mM imidazole, 300 mM NaCl, 20 mM
Light Source (SLS) in Villigen. This dataset was used to solve andTris-HCl [pH 7.4]). The cells were disrupted in a French press at
refine the structure initially. Later, slightly higher resolution data1500 psi and the lysate was centrifuged at 39,000  g for 40 min
were collected at the ID14-14 beam line at the ESRF Grenoble.to remove debris. The N-terminal (His)6-tagged TAP/SPF was puri-
Redundant datasets were collected at the peak wavelength, whichfied from the supernatant by affinity chromatography on 10 ml of
was determined experimentally by fluorescence scans. Data wereNi-NTA SUPERFLOW (Quiagen, Basel, Switzerland) according to
integrated and scaled with MOSFLM/SCALA [37, 38] or XDS [39,the user manual. Briefly, the supernatant was loaded to the column
40]. Data collection statistics are given in Table 1. Twenty out of 30equilibrated in binding buffer and subsequently washed with 25
expected selenium positions were determined using Shake-and-volumes of wash buffer (50 mM imidazole, 300 mM NaCl, 20 mM
Bake version 2.1 [41]. These selenium positions were refined andTris-HCl [pH 7.4]). N-terminal (His)6-tagged TAP/SPF was eluted with
phases were computed using SOLVE 2.01 [42], resulting in a figure-three volumes of elution buffer (200 mM imidazole, 300 mM NaCl,
of-merit of 0.34 at 2.25 A˚ resolution. Solvent modification was ef-20 mM Tris-HCl [pH 7.4]) and the (His)6-tag was cleaved by incubat-
fected with RESOLVE 2.01 [43] and increased the figure-of-merit toing the eluate with 20 units of thrombin protease (Amersham Phar-
0.58 at 2.05 A˚ resolution using the SLS data. The resulting electronmacia Biotech Europe GmbH, Du¨bendorf, Switzerland) at 4C over-
density map was easily interpretable. Further density modificationnight. The protein concentration was determined by the Bradford
was carried out using ArpWarp [44] and concomitantly a partialmethod [33]. Typical yields were 35–40 mg of pure TAP/SPF as
model including side chains was built automatically. The resultingjudged by SDS-PAGE.
model was completed using O [45]. Refinement was carried out
with CNS [46] against the anomalous peak data. Care was takenLipid Complexes and Electrospray Mass Spectrometry
to partition both Friedel mates either in the test or working set.All analytical-grade chemicals as well as octyl -D-glucopyranoside,
Anomalous scattering factors for selenium were refined using CNSD--tocopherol, and L--phosphatidylinositol were obtained from
after the model had reached an Rfree of 0.28. In the final stages ofSigma (St. Louis, MO). Lipid vesicles were prepared by suspending
refinement, NCS restrains were removed. This procedure wasthe corresponding lipid in water followed by sonication for 30 min
judged to be valid by the drop in both R and Rfree by about 1%. Theat 4C. All vesicle containing solutions were centrifuged for 20 min
final model has good stereochemistry and only 1.3% outliers in aat 15,000  g before use. Vesicels containing 10 mol% squalene or
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